It's all good news at Protherics.

Agreed Red Ninja; once the new shares are traded and the acquisitions/licences finalised, the market will show an objective view of the company prospects for 2007-2010.

After this week though, the company needs to buckle down and deliver a steady flow of positive and re-assuring news releases to move the sp back to the £1 area.

News will be thin on the ground though, since we are in a re-jigging mode for manufacturing and gearing up for trials later in the year.
Some early news from the phase 2 trials on Oncogel will help, but the key announcement for me will be the European approvel for Voraxaze --any body know when this is expected?